Katelyn Mason, PA
Physician Assistant · Myrtle Beach, SCNPI 1356984322
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by AbbVie at 58.2% of the total. 2025 is the largest year on record at $5,938, 2.8 times the $2,088 reported in 2021. Among physician assistant clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 299 payments — averaging $34.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Teva Pharmaceuticals USA, Inc.$1K
- Acadia Pharmaceuticals Inc$374
- Pfizer$282
- MDD US Operations, LLC$190
- Lundbeck LLC$185
- plus $2K from 31 others
What the payments were for
- Speaking & faculty fees$4,80946%
- Travel & lodging$941%
- Food & beverage$5,54753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 79 | $6,077 |
| Teva Pharmaceuticals USA, Inc. | 80 | $1,358 |
| Acadia Pharmaceuticals Inc | 12 | $374 |
| Pfizer | 17 | $282 |
| MDD US Operations, LLC | 2 | $190 |
| Lundbeck LLC | 10 | $185 |
| UCB, Inc. | 6 | $156 |
| Biohaven Pharmaceuticals, Inc. | 12 | $154 |
| Novartis | 8 | $152 |
| AstraZeneca | 5 | $138 |
| Biogen | 4 | $131 |
| Lilly USA, LLC | 6 | $118 |
| Eisai Inc. | 5 | $106 |
| Amgen | 5 | $90 |
| Bristol Myers Squibb | 4 | $75 |
| Johnson & Johnson | 4 | $70 |
| Upsher-smith Laboratories LLC | 4 | $69 |
| SK Life Science, Inc. | 3 | $64 |
| Aquestive Therapeutics, Inc. | 3 | $59 |
| EMD Serono, Inc. | 4 | $56 |
| Sanofi | 2 | $52 |
| Neurocrine Biosciences, Inc. | 2 | $51 |
| Mallinckrodt Hospital Products Inc. | 2 | $50 |
| Boston Scientific | 1 | $49 |
| Kyowa Kirin, Inc. | 3 | $47 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Acorda Therapeutics, Inc | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| TG Therapeutics, Inc. | 2 | $33 |
| Amneal Pharmaceuticals LLC | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Harmony Biosciences LLC | 1 | $22 |
| Cala Health, Inc. | 1 | $15 |
| Neurelis, Inc. | 1 | $15 |
| Adamas Pharmaceuticals, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,450 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 18 | $125,002 |
| Aimovig AutoinjectorErenumab-Aooe | 72 | $99,445 |
| Nurtec OdtRimegepant Sulfate | 54 | $77,345 |
| UbrelvyUbrogepant | 47 | $72,650 |
| QuliptaAtogepant | 46 | $67,832 |
| NuplazidPimavanserin Tartrate | 12 | $61,135 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 23 | $23,146 |
| Memantine Hcl | 321 | $14,582 |
| RivastigmineRivastigmine Tartrate | 71 | $5,521 |
| Gabapentin | 296 | $5,299 |
| Donepezil Hcl | 303 | $4,171 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 160 | $4,113 |
| Levetiracetam | 134 | $3,682 |
| Primidone | 151 | $3,270 |
| Duloxetine Hcl | 100 | $2,963 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $6,077 | $140,48393 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $1,358 | $125,00218 claims |
| PfizerNurtec Odt | $282 | $77,34554 claims |
| Acadia Pharmaceuticals IncNuplazid | $374 | $61,13512 claims |
| Upsher-smith Laboratories LLCTopiramate | $69 | $1,476105 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Myrtle Beach
- Michael AsburyMyrtle Beach$25K
- Rebecca VaglioMyrtle Beach$14K
- Benjamin AddyWest Columbia$377K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- Nicole KeeterFort Mill$129K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Vicki RobertsWest Columbia$77K
- Eric ShoupColumbia$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.